📢 Too many exams? Don’t know which one suits you best? Book Your Free Expert 👉 call Now!


    Question

    Which company developed the gene therapy ITVISMA for

    spinal muscular atrophy?
    A Pfizer Correct Answer Incorrect Answer
    B Roche Correct Answer Incorrect Answer
    C Novartis Correct Answer Incorrect Answer
    D AstraZeneca Correct Answer Incorrect Answer
    E Johnson & Johnson Correct Answer Incorrect Answer

    Solution

    The report mentions that ITVISMA was developed by Novartis, targeting the genetic cause of spinal muscular atrophy.

    Practice Next
    More Beepedia Questions

    Relevant for Exams:

    ask-question